{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T03:59:03Z","timestamp":1787025543861,"version":"build-2736575974"},"reference-count":48,"publisher":"IMR Press","issue":"3","license":[{"start":{"date-parts":[[2022,3,16]],"date-time":"2022-03-16T00:00:00Z","timestamp":1647388800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Front. Biosci. (Landmark Ed)"],"abstract":"<jats:p>Background: Unstable angina pectoris (UAP) is a type of Coronary artery disease (CAD) characterized by a series of angina symptoms. Insulin-like growth factor 1 (IGF-1) system may be related to CAD. However, the correlation between the IGF-1 system, metabolism, and gut microbiota has not been studied. In the present study, we investigated the alterations of serum IGF-1 system, metabolomics, and gut microbiota in patients with UAP. Methods: Serum and stool samples from healthy volunteers and UAP patients were collected. Serum metabolomics, PAPP-A, IGF-1, IGFBP-4, STC2, hs-CRP, TNF-\u03b1, and IL-6 were detected in serum samples by LC-MS, and commercial ELISA kits, respectively. Fecal short-chain fatty acids (SCFAs) were measured by gas chromatography. 16S rDNA was used to measure the changes of the gut microbiota. The correlation of the above indicators was analyzed. Results: There were 24 upregulated and 31 downregulated metabolites in the serum of UAP patients compared to those in the controls. Pathway analysis showed that these metabolites were enriched in pathways including linoleic acid metabolism, amino acid metabolism, starch metabolism, sucrose metabolism, and citrate cycle (TCA cycle), etc. Additionally, the UAP patients had lower fecal levels of 2-hydroxyisobutyric acid and succinic acid. 16S rDNA sequencing results showed that the relative abundances of Bacteroidetes, Synergistetes, Lactobacillaceae, Burkholderiaceae, Synergistaceae, and Subdoligranulum were significantly higher in the UAP patients than the healthy subjects. Moreover, the UAP patients had lower serum IGF-1, IGFBP-4, and STC2 and higher serum inflammatory cytokines (hs-CRP, TNF-\u03b1, and IL-6) levels than the healthy controls. Furthermore, there was a strong correlation between serum amino acids and IL-6, which played an important role in the development of UAP. Conclusions: These results indicated that the UAP patients had decreased serum IGF-1 level and imbalanced amino acids metabolism, which may be caused by the altered gut microbiota. It may provide a new therapeutic strategy for unstable angina pectoris.<\/jats:p>","DOI":"10.31083\/j.fbl2703100","type":"journal-article","created":{"date-parts":[[2022,3,18]],"date-time":"2022-03-18T05:28:02Z","timestamp":1647581282000},"source":"Crossref","is-referenced-by-count":13,"title":["Alterations in the fecal microbiota and serum metabolome in unstable angina pectoris patients"],"prefix":"10.31083","volume":"27","author":[{"given":"Langsha","family":"Liu","sequence":"first","affiliation":[{"name":"Department of Cardiac Surgery, Xiangya Hospital, Central South University, 410008 Changsha, Hunan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanyan","family":"Luo","sequence":"first","affiliation":[{"name":"Department of Cardiac Surgery, Xiangya Hospital, Central South University, 410008 Changsha, Hunan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"16242","published-online":{"date-parts":[[2022,3,16]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","unstructured":"Xiaomeng Z, Jiarui W, Bing Z, Wei Z. Danshenchuanxiongqin injection in the treatment of unstable angina pectoris: a systematic review and Meta-analysis. Journal of Traditional Chinese Medicine. 2016; 36: 144\u2013150.","DOI":"10.1016\/S0254-6272(16)30020-6"},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"Juul A, Scheike T, Davidsen M, Gyllenborg J, J\u00f8rgensen T. Low serum insulin-like growth factor i is associated with increased risk of ischemic heart disease: a population-based case-control study. Circulation. 2002; 106: 939\u2013944.","DOI":"10.1161\/01.CIR.0000027563.44593.CC"},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"Laughlin GA, Barrett-Connor E, Criqui MH, Kritz-Silverstein D. The Prospective Association of Serum Insulin-Like Growth Factor i (IGF-i) and IGF-Binding Protein-1 Levels with all Cause and Cardiovascular Disease Mortality in Older Adults: the Rancho Bernardo Study. Te Journal of Clinical Endocrinology & Metabolism. 2004; 89: 114\u2013120.","DOI":"10.1210\/jc.2003-030967"},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"Delafontaine P, Song Y, Li Y. Expression, regulation, and function of IGF-1, IGF-1R, and IGF-1 binding proteins in blood vessels. Arteriosclerosis, Thrombosis, and Vascular Biology. 2004; 24: 435\u2013444.","DOI":"10.1161\/01.ATV.0000105902.89459.09"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"Harrington SC, Simari RD, Conover CA. Genetic deletion of pregnancy-associated plasma protein-a is associated with resistance to atherosclerotic lesion development in apolipoprotein E-deficient mice challenged with a high-fat diet. Circulation Research. 2007; 100: 1696\u20131702.","DOI":"10.1161\/CIRCRESAHA.106.146183"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"Hjortebjerg R, Lindberg S, Pedersen S, Mogelvang R, Jensen JS, Oxvig C, et al. Insulin-Like Growth Factor Binding Protein 4 Fragments Provide Incremental Prognostic Information on Cardiovascular Events in Patients with ST-Segment Elevation Myocardial Infarction. Journal of the American Heart Association. 2017; 6: e005358.","DOI":"10.1161\/JAHA.116.005358"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"Conover CA, Mason MA, Bale LK, Harrington SC, Nyegaard M, Oxvig C, et al. Transgenic overexpression of pregnancy-associated plasma protein-a in murine arterial smooth muscle accelerates atherosclerotic lesion development. American Journal of Physiology-Heart and Circulatory Physiology. 2010; 299: H284\u2013H291.","DOI":"10.1152\/ajpheart.00904.2009"},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"Bayes-Genis A, Conover CA, Overgaard MT, Bailey KR, Christiansen M, Holmes DR, et al. Pregnancy-associated plasma protein a as a marker of acute coronary syndromes. Te New England Journal of Medicine. 2001; 345: 1022\u20131029.","DOI":"10.1056\/NEJMoa003147"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"Jepsen MR, Kl\u00f8verpris S, Mikkelsen JH, Pedersen JH, F\u00fcchtbauer E, Laursen LS, et al. Stanniocalcin-2 inhibits mammalian growth by proteolytic inhibition of the insulin-like growth factor axis. Te Journal of Biological Chemistry. 2015; 290: 3430\u20133439.","DOI":"10.1074\/jbc.M114.611665"},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"Liu H, Chen X, Hu X, Niu H, Tian R, Wang H, et al. Alterations in the gut microbiome and metabolism with coronary artery disease severity. Microbiome. 2019; 7: 68.","DOI":"10.1186\/s40168-019-0683-9"},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"Cui L, Zhao T, Hu H, Zhang W, Hua X. Association Study of Gut Flora in Coronary Heart Disease through High-Throughput Sequencing. BioMed Research International. 2017; 2017: 3796359.","DOI":"10.1155\/2017\/3796359"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"Yan J, Herzog JW, Tsang K, Brennan CA, Bower MA, Garrett WS, et al. Gut microbiota induce IGF-1 and promote bone formation and growth. Proceedings of the National Academy of Sciences of the United States of America. 2016; 113: E7554\u2013E7563.","DOI":"10.1073\/pnas.1607235113"},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"Yan J, Charles JF. Gut Microbiota and IGF-1. Calcified Tissue International. 2018; 102: 406\u2013414.","DOI":"10.1007\/s00223-018-0395-3"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"Dong Z, Zhang J, Luo Y, Zhao M, Cai J, Cheng S, et al. The correlation between trimethylamine N-oxide, lipoprotein ratios, and conventional lipid parameters in patients with unstable angina pectoris. Bioscience Reports. 2020; 40: BSR20192657.","DOI":"10.1042\/BSR20192657"},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"Calder\u00f3n-P\u00e9rez L, Gosalbes MJ, Yuste S, Valls RM, Pedret A, Llaurad\u00f3 E, et al. Gut metagenomic and short chain fatty acids signature in hypertension: a cross-sectional study. Scientific Reports. 2020; 10: 6436.","DOI":"10.1038\/s41598-020-63475-w"},{"key":"ref16","doi-asserted-by":"crossref","unstructured":"Jadoon A, Mathew A, Byun J, Gadegbeku C, Gipson D, Afshinnia F, et al. Gut Microbial Product Predicts Cardiovascular Risk in Chronic Kidney Disease Patients. American Journal of Nephrology. 2018; 48: 269\u2013277.","DOI":"10.1159\/000493862"},{"key":"ref17","doi-asserted-by":"crossref","unstructured":"Laborde CM, Mourino-Alvarez L, Posada-Ayala M, Alvarez-Llamas G, Serranillos-Reus MG, Moreu J, et al. Plasma metabolomics reveals a potential panel of biomarkers for early diagnosis in acute coronary syndrome. Metabolomics. 2014; 10: 414\u2013424.","DOI":"10.1007\/s11306-013-0595-9"},{"key":"ref18","doi-asserted-by":"crossref","unstructured":"He W, Miao FJ, Lin DC, Schwandner RT, Wang Z, Gao J, et al. Citric acid cycle intermediates as ligands for orphan G-protein-coupled receptors. Nature. 2004; 429: 188\u2013193.","DOI":"10.1038\/nature02488"},{"key":"ref19","doi-asserted-by":"crossref","unstructured":"Binu S, Soumya SJ, Sudhakaran PR. Metabolite control of angiogenesis: angiogenic effect of citrate. Journal of Physiology and Biochemistry. 2013; 69: 383\u2013395.","DOI":"10.1007\/s13105-012-0220-9"},{"key":"ref20","doi-asserted-by":"crossref","unstructured":"Mathew AV, Jaiswal M, Ang L, Michailidis G, Pennathur S, Pop-Busui R. Impaired Amino Acid and TCA Metabolism and Cardiovascular Autonomic Neuropathy Progression in Type 1 Diabetes. Diabetes. 2019; 68: 2035\u20132044.","DOI":"10.2337\/db19-0145"},{"key":"ref21","doi-asserted-by":"crossref","unstructured":"Tao T, He T, Wang X, Liu X. Metabolic Profiling Analysis of Patients with Coronary Heart Disease Undergoing Xuefu Zhuyu Decoction Treatment. Frontiers in Pharmacology. 2019; 10: 985.","DOI":"10.3389\/fphar.2019.00985"},{"key":"ref22","doi-asserted-by":"crossref","unstructured":"Takahashi T. Essential and Non-Essential Amino Acids in Relation to Glutamate. Te Open Nutraceuticals Journal. 2011; 4: 205\u2013212.","DOI":"10.2174\/1876396001104010205"},{"key":"ref23","doi-asserted-by":"crossref","unstructured":"Welsh P, Rankin N, Li Q, Mark PB, W\u00fcrtz P, Ala-Korpela M, et al. Circulating amino acids and the risk of macrovascular, microvascular and mortality outcomes in individuals with type 2 diabetes: results from the ADVANCE trial. Diabetologia. 2018; 61: 1581\u20131591.","DOI":"10.1007\/s00125-018-4619-x"},{"key":"ref24","doi-asserted-by":"crossref","unstructured":"Ottosson F, Smith E, Melander O, Fernandez C. Altered Asparagine and Glutamate Homeostasis Precede Coronary Artery Disease and Type 2 Diabetes. Te Journal of Clinical Endocrinology and Metabolism. 2018; 103: 3060\u20133069.","DOI":"10.1210\/jc.2018-00546"},{"key":"ref25","doi-asserted-by":"crossref","unstructured":"Zheng Y, Hu FB, Ruiz\u2010Canela M, Clish CB, Dennis C, Salas\u2010Salvado J, et al. Metabolites of Glutamate Metabolism are Associated with Incident Cardiovascular Events in the PREDIMED PREvenci\u00f3n con DIeta MEDiterr\u00e1nea (PREDIMED) Trial. Journal of the American Heart Association. 2016; 5: e003755.","DOI":"10.1161\/JAHA.116.003755"},{"key":"ref26","doi-asserted-by":"crossref","unstructured":"Zhao JV, Kwok MK, Schooling CM. Effect of glutamate and aspartate on ischemic heart disease, blood pressure, and diabetes: a Mendelian randomization study. The American Journal of Clinical Nutrition. 2019; 109: 1197\u20131206.","DOI":"10.1093\/ajcn\/nqy362"},{"key":"ref27","doi-asserted-by":"crossref","unstructured":"Zhou W, Cheng Y, Zhu P, Nasser MI, Zhang X, Zhao M. Implication of Gut Microbiota in Cardiovascular Diseases. Oxidative Medicine and Cellular Longevity. 2020; 2020: 1\u201314.","DOI":"10.1155\/2020\/5394096"},{"key":"ref28","doi-asserted-by":"crossref","unstructured":"Gao J, Yan K, Wang J, Dou J, Wang J, Ren M, et al. Gut microbial taxa as potential predictive biomarkers for acute coronary syndrome and post-STEMI cardiovascular events. Scientific Reports. 2020; 10: 2639.","DOI":"10.1038\/s41598-020-59235-5"},{"key":"ref29","doi-asserted-by":"crossref","unstructured":"Kazemian N, Mahmoudi M, Halperin F, Wu JC, Pakpour S. Gut microbiota and cardiovascular disease: opportunities and challenges. Microbiome. 2020; 8: 36.","DOI":"10.1186\/s40168-020-00821-0"},{"key":"ref30","doi-asserted-by":"crossref","unstructured":"Wang Z, Zhao Y. Gut microbiota derived metabolites in cardiovascular health and disease. Protein & Cell. 2018; 9: 416\u2013431.","DOI":"10.1007\/s13238-018-0549-0"},{"key":"ref31","doi-asserted-by":"crossref","unstructured":"Wang DD, Nguyen LH, Li Y, Yan Y, Ma W, Rinott E, et al. The gut microbiome modulates the protective association between a Mediterranean diet and cardiometabolic disease risk. Nature Medicine. 2021; 27: 333\u2013343.","DOI":"10.1038\/s41591-020-01223-3"},{"key":"ref32","doi-asserted-by":"crossref","unstructured":"Avery EG, Bartolomaeus H, Maifeld A, Marko L, Wiig H, Wilck N, et al. The Gut Microbiome in Hypertension. Circulation Research. 2021; 128: 934\u2013950.","DOI":"10.1161\/CIRCRESAHA.121.318065"},{"key":"ref33","doi-asserted-by":"crossref","unstructured":"Zheng Y, Wu T, Liu Z, Li A, Guo Q, Ma Y, et al. Gut Microbiome-Based Diagnostic Model to Predict Coronary Artery Disease. Journal of Agricultural and Food Chemistry. 2020; 68: 3548\u20133557.","DOI":"10.1021\/acs.jafc.0c00225"},{"key":"ref34","doi-asserted-by":"crossref","unstructured":"Pedersen HK, Gudmundsdottir V, Nielsen HB, Hyotylainen T, Nielsen T, Jensen BAH, et al. Human gut microbes impact host serum metabolome and insulin sensitivity. Nature. 2016; 535: 376\u2013381.","DOI":"10.1038\/nature18646"},{"key":"ref35","doi-asserted-by":"crossref","unstructured":"Hall AE, Engevik MA, Oezguen N, Haag A, Versalovic J. ClC transporter activity modulates histidine catabolism in Lactobacillus reuteri by altering intracellular pH and membrane potential. Microbial Cell Factories. 2019; 18: 212.","DOI":"10.1186\/s12934-019-1264-0"},{"key":"ref36","doi-asserted-by":"crossref","unstructured":"J\u00e4ger R, Zaragoza J, Purpura M, Iametti S, Marengo M, Tinsley GM, et al. Probiotic Administration Increases Amino Acid Absorption from Plant Protein: a Placebo-Controlled, Randomized, Double-Blind, Multicenter, Crossover Study. Probiotics and Antimicrobial Proteins. 2020; 12: 1330\u20131339.","DOI":"10.1007\/s12602-020-09656-5"},{"key":"ref37","doi-asserted-by":"crossref","unstructured":"Emoto T, Yamashita T, Sasaki N, Hirota Y, Hayashi T, So A, et al. Analysis of Gut Microbiota in Coronary Artery Disease Patients: a Possible Link between Gut Microbiota and Coronary Artery Disease. Journal of Atherosclerosis and Thrombosis. 2016; 23: 908\u2013921.","DOI":"10.5551\/jat.32672"},{"key":"ref38","doi-asserted-by":"crossref","unstructured":"Kummen M, Mayerhofer CCK, Vestad B, Broch K, Awoyemi A, Storm-Larsen C, et al. Gut Microbiota Signature in Heart Failure Defined from Profiling of 2 Independent Cohorts. Journal of the American College of Cardiology. 2018; 71: 1184\u20131186.","DOI":"10.1016\/j.jacc.2017.12.057"},{"key":"ref39","doi-asserted-by":"crossref","unstructured":"Gerasimidis K, Bryden K, Chen X, Papachristou E, Verney A, Roig M, et al. The impact of food additives, artificial sweeteners and domestic hygiene products on the human gut microbiome and its fibre fermentation capacity. European Journal of Nutrition. 2020; 59: 3213\u20133230.","DOI":"10.1007\/s00394-019-02161-8"},{"key":"ref40","doi-asserted-by":"crossref","unstructured":"Gomez-Arango LF, Barrett HL, McIntyre HD, Callaway LK, Morrison M, Dekker Nitert M. Connections between the Gut Microbiome and Metabolic Hormones in Early Pregnancy in Overweight and Obese Women. Diabetes. 2016; 65: 2214\u20132223.","DOI":"10.2337\/db16-0278"},{"key":"ref41","doi-asserted-by":"crossref","unstructured":"Liang Y, Ming Q, Liang J, Zhang Y, Zhang H, Shen T. Gut microbiota dysbiosis in polycystic ovary syndrome: association with obesity \u2014 a preliminary report. Canadian Journal of Physiology and Pharmacology. 2020; 98: 803\u2013809.","DOI":"10.1139\/cjpp-2019-0413"},{"key":"ref42","doi-asserted-by":"crossref","unstructured":"Ziganshina EE, Sharifullina DM, Lozhkin AP, Khayrullin RN, Ignatyev IM, Ziganshin AM. Bacterial Communities Associated with Atherosclerotic Plaques from Russian Individuals with Atherosclerosis. PLoS ONE. 2016; 11: e0164836.","DOI":"10.1371\/journal.pone.0164836"},{"key":"ref43","doi-asserted-by":"crossref","unstructured":"Hjortebjerg R, Rasmussen LM, Gude MF, Irmukhamedov A, Riber LP, Frystyk J, et al. Local IGF Bioactivity Associates with High PAPP-a Activity in the Pericardial Cavity of Cardiovascular Disease Patients. The Journal of Clinical Endocrinology & Metabolism. 2020; 105: e4083\u2013e4093.","DOI":"10.1210\/clinem\/dgaa617"},{"key":"ref44","doi-asserted-by":"crossref","unstructured":"Anastasilakis AD, Koulaxis D, Upadhyay J, Pagkalidou E, Kefala N, Perakakis N, et al. Free IGF-1, Intact IGFBP-4, and PicoPAPP-a are Altered in Acute Myocardial Infarction Compared to Stable Coronary Artery Disease and Healthy Controls. Hormone and Metabolic Research. 2019; 51: 112\u2013119.","DOI":"10.1055\/a-0794-6163"},{"key":"ref45","doi-asserted-by":"crossref","unstructured":"Steffensen LB, Conover CA, Bj\u00f8rklund MM, Ledet T, Bentzon JF, Oxvig C. Stanniocalcin-2 overexpression reduces atherosclerosis in hypercholesterolemic mice. Atherosclerosis. 2016; 248: 36\u201343.","DOI":"10.1016\/j.atherosclerosis.2016.02.026"},{"key":"ref46","doi-asserted-by":"crossref","unstructured":"Ozeren A, Aydin M, Tokac M, Demircan N, Unalacak M, Gurel A, et al. Levels of serum IL-1beta, IL-2, IL-8 and tumor necrosis factor-alpha in patients with unstable angina pectoris. Mediators of Inflammation. 2003; 12: 361\u2013365.","DOI":"10.1080\/09629350310001633360"},{"key":"ref47","doi-asserted-by":"crossref","unstructured":"Jia Y, Wen W, Yang Y, Huang M, Ning Y, Jiao X, et al. The clinical role of combined serum C1q and hsCRP in predicting coronary artery disease. Clinical Biochemistry. 2021; 93: 50\u201358.","DOI":"10.1016\/j.clinbiochem.2021.04.004"},{"key":"ref48","unstructured":"Al-Karkhi IH, Ibrahim AE, Yaseen AK. Levels of insulin, IL-6 and CRP in patients with unstable angina. Advances in Clinical and Experimental Medicine. 2013; 22: 655\u2013658."}],"container-title":["Frontiers in Bioscience-Landmark"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.imrpress.com\/journal\/FBL\/27\/3\/10.31083\/j.fbl2703100","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,27]],"date-time":"2024-11-27T06:53:58Z","timestamp":1732690438000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.imrpress.com\/journal\/FBL\/27\/3\/10.31083\/j.fbl2703100"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,16]]},"references-count":48,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022]]}},"alternative-id":["S2768-6701(22)00438-5"],"URL":"https:\/\/doi.org\/10.31083\/j.fbl2703100","relation":{},"ISSN":["2768-6701","2768-6698"],"issn-type":[{"value":"2768-6701","type":"print"},{"value":"2768-6698","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,16]]},"article-number":"100"}}